doi: 10.58347/tml.2023.1673a.
Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration
- PMID: 37020339
- DOI: 10.58347/tml.2023.1673a
Item in Clipboard
Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration
Med Lett Drugs Ther.
.
No abstract available
Keywords: Syfovre; adverse effects; age-related macular degeneration; dosage; efficacy; eye; pegcetacoplan; safety.
Similar articles
-
Avacincaptad pegol (Izervay) for geographic atrophy in age-related macular degeneration.Med Lett Drugs Ther. 2024 Jan 22;66(1694):15-16. doi: 10.58347/tml.2024.1694d. Med Lett Drugs Ther. 2024. PMID: 38212259 No abstract available.
-
Advancements in the treatment of geographic atrophy: focus on pegcetacoplan in age-related macular degeneration.Ann Med Surg (Lond). 2023 Nov 1;85(12):6067-6077. doi: 10.1097/MS9.0000000000001466. eCollection 2023 Dec. Ann Med Surg (Lond). 2023. PMID: 38098608 Free PMC article. Review.
-
Treatment of geographic atrophy: an update on data related to pegcetacoplan.Curr Opin Ophthalmol. 2024 Jan 1;35(1):64-72. doi: 10.1097/ICU.0000000000000845. Epub 2023 Oct 10. Curr Opin Ophthalmol. 2024. PMID: 37815317 Review.
-
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.Ophthalmology. 2021 Sep;128(9):1325-1336. doi: 10.1016/j.ophtha.2021.02.025. Epub 2021 Mar 10. Ophthalmology. 2021. PMID: 33711380 Clinical Trial.
-
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.Ophthalmology. 2020 Feb;127(2):186-195. doi: 10.1016/j.ophtha.2019.07.011. Epub 2019 Jul 16. Ophthalmology. 2020. PMID: 31474439 Clinical Trial.
Cited by
-
AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model.Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):25. doi: 10.1167/iovs.64.10.25. Invest Ophthalmol Vis Sci. 2023. PMID: 37471073 Free PMC article.
-
Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease.Stem Cells Transl Med. 2024 Apr 15;13(4):332-345. doi: 10.1093/stcltm/szae005. Stem Cells Transl Med. 2024. PMID: 38417110 Free PMC article. Review.
-
Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration.Diagnostics (Basel). 2023 Dec 10;13(24):3635. doi: 10.3390/diagnostics13243635. Diagnostics (Basel). 2023. PMID: 38132220 Free PMC article. Review.
-
Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.Stem Cells Transl Med. 2024 Apr 15;13(4):317-331. doi: 10.1093/stcltm/szae004. Stem Cells Transl Med. 2024. PMID: 38394392 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
